Scientific Intake is a Medical Device and Digital Health company that is scientifically-reinventing weight management with our flagship product the SmartByteTM Weight Management System. SmartByte seamlessly integrates proprietary medical technology, behavioral science and digital intelligence to help people manage their weight and live healthy lives. SmartByte is the first and only, FDA-cleared personal weight management system. Privately held and headquartered in Lawrence, Massachusetts, Scientific Intake’s mission is to help people reduce their risk of obesity-related chronic diseases through weight management.


Our Team

Marc Gibeley
Chief Executive Officer

Tony Tremaglio
Chief Marketing Officer

Richard Schneider
Chief Operating Officer


Adam Berman
Vice President of Sales

Wendy Lewis

Kristen Callahan


Bill Reissfelder

Lisa Caruso
Lead Coach

Meredith Liss
Lead Dietician

Jenny - June 2017.jpg

Jenny Hapgood
Consultant – Behavioral Science & Coaching

Arna Ionescu Stoll
Consultant – Product Design & Development

Dinah - June 2017.jpg

Dinah Shore Myers
Consultant – Quality

Gina Nagvajara
Consultant – Regulatory Affairs


Our Scientific Advisory Board


Donna Ryan, MD, FACP
Chief Medical Officer

Donna Ryan, MD, FACP

Donna H. Ryan, MD is Professor Emerita and Executive Director at Pennington Biomedical Research Center in Baton Rouge Louisiana, where for 22 years she oversaw clinical research as Associate Executive Director. Her career spanned clinical and population research, clinical care and teaching in obesity. She is formerly President of The Obesity Society and currently President of the World Obesity Federation. In her research career, she was an investigator on the teams that developed and executed studies in lifestyle intervention such as the DASH (Dietary Approaches to Stop Hypertension), POUNDS Lost, DPP (Diabetes Prevention Program) and Look AHEAD Studies. Dr. Ryan’s scholarly activities include authorship of more than 200 original publications and 45 books, chapters and reviews, primarily in the field of obesity. She is Associate Editor-in-Chief of Obesity. She served as co-chair of the Expert Panel that produced the AHA/ACC/TOS 2013 Guidelines for the Diagnosis and Management of Obesity. Over her career, she has served as a consultant and advisor to industry and has been a scientific advisor to many companies, most recently Novo Nordisk, Takeda, Janssen, Pfizer, Amgen, Real Appeal, Gila Therapeutics and Scientific Intake.


Caroline Apovian, MD, FACP, FACN
Advisory Board

Caroline Apovian, MD, FACP, FACN

Caroline M. Apovian, MD grew up in Fort Lee, New Jersey. She received her BA in Biochemistry at Barnard College and graduated with her medical degree from University of Medicine & Dentistry of New Jersey. She completed her residency in internal medicine at Brigham and Women’s Hospital in Boston and her fellowship in Nutrition Support at New England Deaconess Hospital under the guidance of Dr. George Blackburn. She was an Instructor of Medicine at Harvard Medical School before joining Boston Medical Center as the Director of the Nutrition and Weight Management Center and Co-Director of the Nutrition Support Service in 2000. Dr. Apovian is Professor of Medicine and Pediatrics in the Section of Endocrinology, Diabetes, and Nutrition at Boston University School of Medicine. She has co-authored over 200 original manuscripts, book chapters, and reviews on the topics of obesity, nutrition, and the relationship between adipose tissue and risk of developing cardiovascular disease. She was on the expert panel for updating the 2013 AHA/ACC/TOS Guideline for the Management of Overweight and Obesity in Adults. Dr. Apovian has given over 100 invited lectures nationally and internationally and was recently appointed President elect of The Obesity Society.

Bruce Bode, MD, FACE
Advisory Board

Bruce Bode, MD, FACE

Dr. Bode is a diabetes specialist with Atlanta Diabetes Associates in Atlanta, Georgia, and is currently on the faculty of Emory University, as a Clinical Associate Professor in the Department of Medicine. Dr. Bode is on the medical advisory boards of Medtronic, Novo Nordisk, Aventis and DexCom. He is a prolific writer with over 200 articles and books in the field of diabetes discussing current and future therapies for people with diabetes.


Our Board of Directors

Bert Fornaciari
Private Investor

Marc Gibeley
Chief Executive Officer

Arthur Gosnell
Stonehurst Capital

William Longley
Founder & Chairman

J. Blake O’Neill
Private Investor & Life Sciences Marketing Executive

Richard Schneider
Private Investor & Chief Operating Officer